During the past decade, Servus Salvus Kft. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Servus Salvus Kft." #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Servus Salvus Kft." are "Autism Spectrum Disorder (ASD)" (2 trials). Many other conditions were trialed in "Servus Salvus Kft." in a lesser frequency.

Most popular intervention types in "Servus Salvus Kft." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BUMETANIDE/S95008" (1 trials), "Bumetanide Oral Solution" (1 trials), "PLACEBO" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Servus Salvus Kft." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Servus Salvus Kft.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Servus Salvus Kft., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Servus Salvus Kft., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".